DATED 17 APRIL 2019 DEED OF CONSENT AND AMENDMENT RELATING TO A £20,455,000 LOAN AGREEMENT DATED 28 SEPTEMBER 2018Mereo Biopharma Group PLC • April 29th, 2019 • Pharmaceutical preparations • Dublin
AMENDMENT NUMBER ONE TO CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • April 29th, 2019 • Mereo Biopharma Group PLC • Pharmaceutical preparations
This Amendment Number One (the “Amendment”) to that certain Contingent Value Rights Agreement, dated as of March 14, 2019, (the “Agreement”), is executed by OncoMed Pharmaceuticals, Inc. a Delaware corporation (the “Company”) as of April 15, 2019 (the “Effective Date”). Capitalized terms used herein, but not defined, shall have the meanings ascribed to them in the Agreement.
